Thursday, July 30, 2015 11:55:20 AM
We have been promised non-dilutive financing for the past three years...
Shareholders were promised to be "taken care of"...
Lympro was to be the "Gold Standard"...
What did we get but a downward spiral since last August...
No updates on RP...
A reverse split from a position of "strength"???
A promise for further dilution by increasing authorized shares...that we all know will become issued and sold for further dilution.
Point is, that there is plenty to be upset about. Management has not been totally honest or upfront with shareholders that got the company this far...some of us have been in AMBS for several years, and are not happy with the acquisitions of assets that require a ton of R&D funds to even investigate whether or not further research is necessary. AMBS cannot and should not continue to finance everything in house...a partner is necessary to avoid some of the dilution. GC said discussions were in the works with a partner more than a year ago! The dilution and decrease in PPS needs to stop! Before much longer, even a turnicate won't help...a limb will have to be removed!
I'm still long, and hoping for the best...but very frustrated as well!
In My Own Personal Opinion Of Course!
Long AMBS!
In My Own Personal Opinion Of Course!
Long ANAS!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM